. Logo of the Australian Department of Defence MinisterspacerNavyspacerArmyspacerAir ForcespacerDepartment
left margin of masthead Masthead :: NAVY News :: The official newspaper of the Royal Australian Navy NAVY Badge

Contents
Top Stories
Letters
Features
Finance
Recreation
Entertainment
Health and Fitness
Sport
About us
Home
Navigation Bar End

 

 

Top Stories

DG Health warning for male members
Counselling not drugs solution for ED

By Tony Underwood
Overweight smokers in the ADF who drink too much or use illicit drugs are more likely to receive counselling than a prescription under the policy for erectile dysfunction (ED) medication just published in a Defence Health Bulletin.
Certain job categories may be off-limits also for the two medications currently approved for use in Australia - Viagra and Cialis - at least when there’s a chance they can impair faculties needed for Defence work.

They will not be prescribed for women.

And those who do receive a prescription from an MO are likely to be limited to four doses per month.

“Risk factors for ED include age, medical conditions, medications and lifestyle factors,” the Director-General Defence Health Service, AIRCDRE Tony Austin said in the document addressing the issue, Defence Health Bulletin No. 4/2003.
AIRCDRE Austin said an Australian survey in 1999 found that the prevalence of impotence was about three per cent in 40-49 year olds and 12 per cent in 50-59 year olds.

“Although the incidence of ED increases with age, it is not an inevitable consequence of aging,” he said.

Medical conditions commonly associated with ED include diabetes, mellitus, hypertension, heart disease, peripheral vascular disease, multiple sclerosis, prostate surgery and trauma or fractures to the pelvic area of spinal cord.

AIRCDRE Austin said however, that it is sometimes difficult to distinguish between the effects of age and a predisposing medical condition. Some medications, including those for blood pressure and psychotropic medications are ‘also implicated’.

“Lifestyle factors such as cigarette smoking, chronic alcohol abuse and obesity are associated,” he said. “Vigorous exercise appears to have a protective effect against ED.”

Defence medical authorities will be looking carefully for the possibility that ED medication can adversely affect the ability of sailors, soldiers and airmen to carry out certain duties.

Pharmacological effects associated with Viagra and Cialis include colour tingeing of the visual scene and decreased blue green colour discrimination and generalised vasodilation associated with a small decrease in blood pressure and dizziness.

As well as canvassing the dosages of the PDE5 (phosphodiesterase type 5) drugs used to treat the condition, the Health Bulletin mandates a thorough clinical assessment to identify contributory medical conditions, medications, psychogenic or lifestyle factors which could contribute to a patient’s impotence.

“If any underlying causes are present and able to be ameliorated, an attempt must be made to do so,” AIRCDRE Austin said.

“Medications contributing to ED may be able to be discontinued or alternatives prescribed.

“Psychosexual therapy, if indicated, may be used in conjunction with other treatment.

“Counselling with regard to lifestyle factors such as obesity, smoking, excessive alcohol or illicit drug use may be appropriate.”

The Health Bulletin adds that provision of PDE5 drugs is to be limited to one packet of four tablets per person per month unless the Senior Medical Officer (SMO) has approved provision of a larger amount.

In terms of job descriptions which might be affected by the drugs, the document says they are not to be prescribed for aircrew or divers who are on active flying or diving status.

AIRCDRE Austin said underlying conditions for aircrew suffering from ED may have ‘flying safety implications’.

But he said aircrew may be permitted to take the medication whilst on active flying status provided they observe a 12-hour temporarily unfit for flying (TMUFF) period after taking the medication.

The document said also the maximum period duration of provision of PDE5 drugs is six months unless continuing treatment is prescribed by the MO.

 

Top of side bar

.

 

 

 

 

 

 

Top Stories | Letters | Features | Finance | Computing | Entertainment | Health & Fitness | Sport | About us